He is the Executive Secretary/CEO of the East African Health Commission www.eahealth.org appointed by the Council of Ministers of the East African Community www.eac.int and he is a professor of medicine at KCMC, Tanzania.
Gibson Kibiki graduated in medicine (MD) in Bulgaria in 1996. He specialized in internal medicine (MMed) in Tanzania in 2003. Between 1998 and 2005 he undertook training programmes in interventional and advanced endoscopy (bronchoscopy, and digestive system endoscopy) in Germany, the Netherlands, and USA. He conducted a series of bronchoscopy-based (basic and clinical) research on co-infection between pulmonary Tuberculosis and Human Immunodeficiency Virus for his PhD thesis, which he completed in 2006 and was awarded a PhD in Medical Sciences at Radboud University, The Netherlands.
Throughout his career he has been immensely involved in clinical services, academics, research, capacity building, and management in the health sector: he established the first in the region endoscopy unit for advanced endoscopic treatment at KCMC, he led the establishment of Kilimanjaro Clinical Research Institute www.kcri.ac.tz as an academic centre for evidence based-medical interventions, he has supervised/mentored more than 70 MSc, MMed, PhD, and Post-Doc fellows from Tanzania and from overseas universities. He has published over 100 peer-reviewed papers. He served as an adjunct Professor at the University of Virginia, USA, and a visiting Lecturer for the Diploma in Tropical Medicine & Hygiene (DTM&H) course at London School of Hygiene and Tropical Medicine, UK. He is a PhD supervisor for Radboud University in the Netherlands, and KCMC in Tanzania. He serves as an external examiner for PhD candidates for various overseas universities.
Prof Kibiki is a member of the Executive Group of PanACEA consortium and a member of various expert committees e.g. the Expert Advisory Panel of the European COMPARE Consortium; Advisory Board of THRiVE consortium, Clinical Trials Technical Committee of Tanzania FDA, member of Data Safety Monitoring Boards of various clinical trials in TB, and HIV. He has led various regional and international research consortia.